RETN and metabolic dysfunction-associated steatohepatitis: Interestingly, elevated levels of resistin have previously been reported in NASH patients [63,64], and IL-27 is known to inhibit T cell responses [65], suggesting that P2RX7 inhibition may reduce the proinflammatory response of not only MOs but also other liver immune cells.